Roy Artal, M.D.
NPI 1720169972 · Pulmonary Disease Physician · Los Angeles, CA
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1720169972
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- A60669 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,010 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 383 | $91 |
| Home Sleep Test (hst) With Type III Portable Monitor, Unattended; Minimum of 4 Channels: 2 Respiratory Movement/Airflow, 1 Ecg/Heart Rate and 1 Oxygen SaturationG0399 | 335 | $75 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 312 | $127 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 172 | $114 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 152 | $76 |
| Sleep Study in Sleep Lab (6 Years Or Older) |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 29 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone Propionate | 67 | 24 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 56 | 12 |
| Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta | 52 | — |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 40 | 19 |
| Azelastine Hcl | 35 | 18 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 30 | 12 |
| Prednisone |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$55,949 across 93 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-10-17
- Last updated
- 2007-07-09
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.